These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 24763838

  • 1. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.
    Makarawate P, Chaosuwannakit N, Vannaprasaht S, Tassaneeyakul W, Sawanyawisuth K.
    Singapore Med J; 2014 Apr; 55(4):217-20. PubMed ID: 24763838
    [Abstract] [Full Text] [Related]

  • 2. SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome.
    Makarawate P, Chaosuwannakit N, Vannaprasaht S, Sahasthas D, Koo SH, Lee EJD, Tassaneeyakul W, Barajas-Martinez H, Hu D, Sawanyawisuth K.
    J Am Heart Assoc; 2017 Jun 05; 6(6):. PubMed ID: 28584071
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, Noda T, Aiba T, Takaki H, Yasuda S, Ogawa H, Shimizu W, Makiyama T, Kimura T, Kamakura S, Kusano K.
    Circ Arrhythm Electrophysiol; 2015 Aug 05; 8(4):785-91. PubMed ID: 26067668
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T, Abe I, Hirota K, Kondo H, Fukui A, Akioka H, Teshima Y, Yufu K, Nakagawa M, Takahashi N.
    Heart Vessels; 2021 Feb 05; 36(2):260-266. PubMed ID: 32833119
    [Abstract] [Full Text] [Related]

  • 5. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H, Reis Santos K, Adragão P, Moscoso Costa F, Galvão Santos P, Carmo P, Cavaco D, Bello Morgado F, Mendes M.
    Rev Port Cardiol; 2015 Jun 05; 34(6):395-402. PubMed ID: 26028488
    [Abstract] [Full Text] [Related]

  • 6. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M.
    Circulation; 2013 Oct 15; 128(16):1739-47. PubMed ID: 23995538
    [Abstract] [Full Text] [Related]

  • 7. Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.
    Andorin A, Behr ER, Denjoy I, Crotti L, Dagradi F, Jesel L, Sacher F, Petit B, Mabo P, Maltret A, Wong LC, Degand B, Bertaux G, Maury P, Dulac Y, Delasalle B, Gourraud JB, Babuty D, Blom NA, Schwartz PJ, Wilde AA, Probst V.
    Heart Rhythm; 2016 Jun 15; 13(6):1274-82. PubMed ID: 26921764
    [Abstract] [Full Text] [Related]

  • 8. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC, Sieira J, Pappaert G, de Asmundis C, Chierchia GB, La Meir M, Sarkozy A, Brugada P.
    J Am Coll Cardiol; 2018 Jan 16; 71(2):148-157. PubMed ID: 29325638
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P.
    J Am Coll Cardiol; 2015 Mar 10; 65(9):879-88. PubMed ID: 25744005
    [Abstract] [Full Text] [Related]

  • 10. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J, Arbelo E, Borras R, Berne P, Tolosana JM, Gomez-Juanatey A, Berruezo A, Campuzano O, Sarquella-Brugada G, Mont L, Brugada R, Brugada J.
    J Am Coll Cardiol; 2017 Oct 17; 70(16):1991-2002. PubMed ID: 29025556
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach.
    Letsas KP, Bazoukis G, Efremidis M, Georgopoulos S, Korantzopoulos P, Fragakis N, Asvestas D, Vlachos K, Saplaouras A, Sakellaropoulou A, Mililis P, Strempelas P, Giannopoulos G, Gavrielatos G, Tzeis S, Kardamis C, Katsivas A, Deftereos S, Stavrakis S, Sideris A.
    Europace; 2019 Dec 01; 21(12):1911-1918. PubMed ID: 31638693
    [Abstract] [Full Text] [Related]

  • 12. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.
    Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jaïs P, Pasquié JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haïssaguerre M, Mansourati J, Clémenty J, Le Marec H.
    Circulation; 2006 Nov 28; 114(22):2317-24. PubMed ID: 17116772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E, IBRYD Study Group.
    Heart Vessels; 2023 May 28; 38(5):680-688. PubMed ID: 36418560
    [Abstract] [Full Text] [Related]

  • 15. Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).
    Milman A, Hochstadt A, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Conte G, Arbelo E, Kamakura T, Aiba T, Napolitano C, Giustetto C, Denjoy I, Juang JJM, Maeda S, Takahashi Y, Leshem E, Michowitz Y, Rahkovich M, Jespersen CH, Wijeyeratne YD, Champagne J, Calo L, Huang Z, Mizusawa Y, Postema PG, Brugada R, Wilde AAM, Yan GX, Behr ER, Tfelt-Hansen J, Hirao K, Veltmann C, Leenhardt A, Corrado D, Gaita F, Priori SG, Kusano KF, Takagi M, Delise P, Brugada J, Brugada P, Nam GB, Probst V, Belhassen B.
    Europace; 2019 May 01; 21(5):796-802. PubMed ID: 30590530
    [Abstract] [Full Text] [Related]

  • 16. Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome.
    Son MK, Byeon K, Park SJ, Kim JS, Nam GB, Choi KJ, Kim YH, Park SW, Kim YH, Park HW, Cho JG, On YK.
    Yonsei Med J; 2014 Jan 01; 55(1):37-45. PubMed ID: 24339285
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The importance of class-I antiarrhythmic drug test in the evaluation of patients with syncope: unmasking Brugada syndrome.
    Roos M, Sarkozy A, Brodbeck J, Henkens S, Chierchia GB, de Asmundis C, Capulzini L, Müller-Burri SA, Yakazi Y, Brugada P.
    J Cardiovasc Electrophysiol; 2012 Mar 01; 23(3):290-5. PubMed ID: 21985403
    [Abstract] [Full Text] [Related]

  • 20. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B, Israeli Working Group on Cardiac Pacing and Electrophysiology.
    Isr Med Assoc J; 2008 Jun 01; 10(6):435-9. PubMed ID: 18669142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.